Why Corindus Vascular Robotics Is Skyrocketing

After management announced that the company is being acquired, shares of Corindus Vascular Robotics (NYSEMKT: CVRS), a medical device company focused on vascular disease, jumped 75% as of 10:30 a.m. EDT on Thursday.

Corindus surprised Wall Street today by announcing that it has agreed to be acquired by Siemens Healthineers (OTC: SMMNY) for $1.1 billion, or $4.28 per share in cash.

The transaction has already been approved by Corindus' Board of Directors and is expected to close in the fourth quarter of 2019, subject to approval by Corindus stockholders.

Quelle Fool.com